PL91030B1 - - Google Patents

Download PDF

Info

Publication number
PL91030B1
PL91030B1 PL1973162559A PL16255973A PL91030B1 PL 91030 B1 PL91030 B1 PL 91030B1 PL 1973162559 A PL1973162559 A PL 1973162559A PL 16255973 A PL16255973 A PL 16255973A PL 91030 B1 PL91030 B1 PL 91030B1
Authority
PL
Poland
Prior art keywords
otbu
glu
ala
ser
pro
Prior art date
Application number
PL1973162559A
Other languages
English (en)
Polish (pl)
Original Assignee
Richter Gedeon Vegyeszeti Gyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar Rt filed Critical Richter Gedeon Vegyeszeti Gyar Rt
Publication of PL91030B1 publication Critical patent/PL91030B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/066General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amido functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/08General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
    • C07K1/088General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing other elements, e.g. B, Si, As
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)
PL1973162559A 1972-05-15 1973-05-15 PL91030B1 (US20030220297A1-20031127-C00009.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI465A HU166913B (US20030220297A1-20031127-C00009.png) 1972-05-15 1972-05-15

Publications (1)

Publication Number Publication Date
PL91030B1 true PL91030B1 (US20030220297A1-20031127-C00009.png) 1977-02-28

Family

ID=11000888

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1973162559A PL91030B1 (US20030220297A1-20031127-C00009.png) 1972-05-15 1973-05-15

Country Status (26)

Country Link
US (1) US3953415A (US20030220297A1-20031127-C00009.png)
JP (1) JPS5516417B2 (US20030220297A1-20031127-C00009.png)
AT (1) AT351683B (US20030220297A1-20031127-C00009.png)
BE (1) BE799552A (US20030220297A1-20031127-C00009.png)
BG (1) BG20341A3 (US20030220297A1-20031127-C00009.png)
CA (1) CA1027111A (US20030220297A1-20031127-C00009.png)
CH (1) CH580064A5 (US20030220297A1-20031127-C00009.png)
CS (1) CS173632B2 (US20030220297A1-20031127-C00009.png)
DD (1) DD105603A5 (US20030220297A1-20031127-C00009.png)
DE (1) DE2324239C3 (US20030220297A1-20031127-C00009.png)
DK (1) DK147944C (US20030220297A1-20031127-C00009.png)
EG (1) EG11309A (US20030220297A1-20031127-C00009.png)
ES (1) ES414589A1 (US20030220297A1-20031127-C00009.png)
FI (1) FI56830C (US20030220297A1-20031127-C00009.png)
FR (1) FR2184814B1 (US20030220297A1-20031127-C00009.png)
GB (1) GB1429251A (US20030220297A1-20031127-C00009.png)
HU (1) HU166913B (US20030220297A1-20031127-C00009.png)
IL (1) IL42108A (US20030220297A1-20031127-C00009.png)
NL (1) NL176946C (US20030220297A1-20031127-C00009.png)
NO (1) NO139268C (US20030220297A1-20031127-C00009.png)
PL (1) PL91030B1 (US20030220297A1-20031127-C00009.png)
RO (1) RO72336A (US20030220297A1-20031127-C00009.png)
SE (1) SE421790B (US20030220297A1-20031127-C00009.png)
SU (1) SU505352A3 (US20030220297A1-20031127-C00009.png)
YU (1) YU36689B (US20030220297A1-20031127-C00009.png)
ZA (1) ZA733242B (US20030220297A1-20031127-C00009.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2296427A1 (fr) * 1974-12-31 1976-07-30 Choay Sa Agent peptidique de regulation de la glycemie
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US6031074A (en) * 1989-08-25 2000-02-29 National Institutes Of Health Automated Peptide design and synthesis
JP2593495Y2 (ja) * 1991-05-31 1999-04-12 矢崎総業株式会社 高圧抵抗電線の端部構造
SE520392C2 (sv) * 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
DE10054687A1 (de) * 2000-11-03 2002-05-16 N Zyme Biotec Gmbh Inhibitoren von Transglutaminasen
CN116761809A (zh) 2021-04-12 2023-09-15 南京汉欣医药科技有限公司 一种高纯的人促肾上腺皮质激素或其类似物及其规模化制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6509727A (US20030220297A1-20031127-C00009.png) * 1965-07-28 1967-01-30
NL6611701A (US20030220297A1-20031127-C00009.png) * 1965-08-24 1967-02-27

Also Published As

Publication number Publication date
RO72336A (ro) 1982-02-26
YU127373A (en) 1982-02-25
GB1429251A (en) 1976-03-24
AU5457673A (en) 1974-10-17
JPS5516417B2 (US20030220297A1-20031127-C00009.png) 1980-05-01
DE2324239B2 (de) 1974-10-10
ATA306973A (de) 1979-01-15
YU36689B (en) 1984-08-31
SE421790B (sv) 1982-02-01
NL176946B (nl) 1985-02-01
DK147944B (da) 1985-01-14
SU505352A3 (ru) 1976-02-28
BE799552A (fr) 1973-08-31
HU166913B (US20030220297A1-20031127-C00009.png) 1975-06-28
JPS49100031A (US20030220297A1-20031127-C00009.png) 1974-09-20
ES414589A1 (es) 1976-02-01
NL176946C (nl) 1985-07-01
US3953415A (en) 1976-04-27
CS173632B2 (US20030220297A1-20031127-C00009.png) 1977-02-28
FI56830C (fi) 1980-04-10
CA1027111A (en) 1978-02-28
NL7306764A (US20030220297A1-20031127-C00009.png) 1973-11-19
CH580064A5 (US20030220297A1-20031127-C00009.png) 1976-09-30
NO139268B (no) 1978-10-23
AT351683B (de) 1979-08-10
ZA733242B (en) 1974-04-24
FR2184814B1 (US20030220297A1-20031127-C00009.png) 1977-04-22
DE2324239A1 (de) 1973-12-06
DE2324239C3 (de) 1975-05-28
IL42108A0 (en) 1973-06-29
DK147944C (da) 1985-08-26
IL42108A (en) 1975-12-31
BG20341A3 (US20030220297A1-20031127-C00009.png) 1975-11-05
DD105603A5 (US20030220297A1-20031127-C00009.png) 1974-05-05
EG11309A (en) 1978-03-29
NO139268C (no) 1979-01-31
FR2184814A1 (US20030220297A1-20031127-C00009.png) 1973-12-28
FI56830B (fi) 1979-12-31

Similar Documents

Publication Publication Date Title
US4737487A (en) VIP type peptides
US4350627A (en) Biologically active peptides
CA1282550C (en) Methods and compositions for preparation of h-arg-x-z-y-tyr-r
EP0123950A2 (en) Intermediates for thymosin alpha 1 and desacetylthymosin alpha 1
JPS63284197A (ja) ホスホリパーゼa↓2‐阻止作用を有するペプチド
PL91030B1 (US20030220297A1-20031127-C00009.png)
EP0123951A2 (en) Intermediates for thymosin alpha 1
EP0452514A1 (en) Peptide and process for preparing cyclic peptide
US5770692A (en) Carbamoylation of amino groups in peptides via N-aryloxycarbonyl intermediates
GB1584669A (en) Process for synthesising peptides containing a sulphated tyrosine residue
HANDA et al. FMOC solid phase synthesis of an endothelin converting enzyme substrate: use of allyl ester as the third orthogonal protecting group
US6448031B1 (en) Process for producing LH-RH derivatives
CA2471723C (en) Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production
KR19980702267A (ko) Nα-2-(4-나이트로페닐설포닐)에톡시카르보닐-아미노산류
EP0311392B1 (en) Solution synthesis of an octapeptide
EP0311391B1 (en) New process for preparing an octapeptide
JPS61286400A (ja) 新規ペプチド
VOSKUYL‐HOLTKAMP et al. STUDIES ON POLYPEPTIDES: XXIX. Synthesis of the N‐Terminal Tetradecapeptide Sequence of Ribonuclease A, Incorporating β‐(3‐Pyridyl)‐L‐Alanine at Position 12
Voskuyl‐Holtkamp et al. STUDIES ON POLYPEPTIDES: XXVI. Synthesis of the N‐Terminal 1–23 Peptide Sequence of Rat Pancreatic Ribonuclease; Enzymatic Activity of the Hybrid Complex with Bovine S‐Protein.
TURÁN et al. ALTERNATIVE SYNTHESIS OF CORTICOTROPIN‐LIKE INTERMEDIATE LOBE PEPTIDE (HUMAN CLIP)
FEHRENTZ et al. Solution synthesis of antigenic and inhibiting peptides of the human renin prosegment‐2: [Tyr 40] preprorenin‐(40–50) peptide methyl ester
FEHRENTZ et al. Solution synthesis of antigenic and inhibiting peptides of the human renin prosegment‐1: [Tyr 47, Nle 53] preprorenin‐(47–60) peptide methyl ester
Fujii et al. Total synthesis of bovine pancreatic ribonuclease A. Part 1. Synthesis of the protected pentadecapeptide ester (positions 110–124)
JPH07118293A (ja) ポリペプチドの製造方法
JPH07118294A (ja) ポリペプチドの製造方法